These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 28129069)
41. Impact of Animated Spokes-Characters in Print Direct-to-Consumer Prescription Drug Advertising: An Elaboration Likelihood Model Approach. Bhutada NS; Rollins BL; Perri M Health Commun; 2017 Apr; 32(4):391-400. PubMed ID: 27315337 [TBL] [Abstract][Full Text] [Related]
42. Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources. DeLorme DE; Huh J; Reid LN Health Mark Q; 2009; 26(4):293-314. PubMed ID: 19916096 [TBL] [Abstract][Full Text] [Related]
43. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Doran E Int J Health Policy Manag; 2016 Feb; 5(5):333-5. PubMed ID: 27239884 [TBL] [Abstract][Full Text] [Related]
44. Is the information "fair and balanced" in direct-to-consumer prescription drug websites? Huh J; Cude BJ J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451 [TBL] [Abstract][Full Text] [Related]
45. Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation. O'Donoghue AC; Johnson M; Sullivan HW; Parvanta S; Ray S; Southwell BG J Health Commun; 2019; 24(4):368-376. PubMed ID: 31012394 [TBL] [Abstract][Full Text] [Related]
46. Choice, Transparency, Coordination, and Quality Among Direct-to-Consumer Telemedicine Websites and Apps Treating Skin Disease. Resneck JS; Abrouk M; Steuer M; Tam A; Yen A; Lee I; Kovarik CL; Edison KE JAMA Dermatol; 2016 Jul; 152(7):768-75. PubMed ID: 27180232 [TBL] [Abstract][Full Text] [Related]
47. Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters". Rollins BL Int J Health Policy Manag; 2016 Feb; 5(4):287-8. PubMed ID: 27239875 [TBL] [Abstract][Full Text] [Related]
48. Experimental evidence of consumer and physician detection and rejection of misleading prescription drug website content. Boudewyns V; Betts KR; Johnson M; Paquin RS; O'Donoghue AC; Southwell BG Res Social Adm Pharm; 2021 Apr; 17(4):733-743. PubMed ID: 32792323 [TBL] [Abstract][Full Text] [Related]
49. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs. Davis JJ J Health Commun; 2000; 5(4):349-69. PubMed ID: 11191018 [TBL] [Abstract][Full Text] [Related]
50. Awareness of and attitudes toward direct-to-consumer prescription drug advertising among young adults. Alperstein NM Health Mark Q; 2014; 31(3):231-45. PubMed ID: 25120044 [TBL] [Abstract][Full Text] [Related]
51. The role of imagination in consumers' processing of visual metaphors in prescription drug advertising. Foreman JR; Hsieh MH; Grover A Health Mark Q; 2019; 36(3):169-185. PubMed ID: 31180277 [TBL] [Abstract][Full Text] [Related]
52. Use of anonymous Web communities and websites by medical consumers in Japan to research drug information. Kishimoto K; Fukushima N Yakugaku Zasshi; 2011; 131(5):685-95. PubMed ID: 21532265 [TBL] [Abstract][Full Text] [Related]
53. Consumer friendly or reader hostile? An evaluation of the readability of DTC print ads. Sheehan K Health Mark Q; 2008; 23(4):1-16. PubMed ID: 19042509 [TBL] [Abstract][Full Text] [Related]
54. Attention to risk information in direct-to-consumer prescription drug print ads: An eye-tracking study. Aikin KJ; Sullivan HW; Caporaso A; Hoverman V; Yan T; Williams D; Crafts J Pharmacoepidemiol Drug Saf; 2023 Mar; 32(3):312-320. PubMed ID: 35864719 [TBL] [Abstract][Full Text] [Related]
55. Trust in online prescription drug information among internet users: the impact on information search behavior after exposure to direct-to-consumer advertising. Menon AM; Deshpande AD; Perri M; Zinkhan GM Health Mark Q; 2002; 20(1):17-35. PubMed ID: 12749596 [TBL] [Abstract][Full Text] [Related]
56. Living in the "land of no"? Consumer perceptions of healthy lifestyle portrayals in direct-to-consumer advertisements of prescription drugs. Frosch DL; May SG; Tietbohl C; Pagán JA Soc Sci Med; 2011 Oct; 73(7):995-1002. PubMed ID: 21843911 [TBL] [Abstract][Full Text] [Related]
57. Do dissonant ad visuals cause consumers to discount prescription drug side effects? Hagenbuch D Health Mark Q; 2019; 36(4):337-353. PubMed ID: 31646956 [TBL] [Abstract][Full Text] [Related]
58. Disease-specific direct-to-consumer advertising of pharmaceuticals: An examination of endorser type and gender effects on consumers' attitudes and behaviors. Bhutada NS; Rollins BL Res Social Adm Pharm; 2015; 11(6):891-900. PubMed ID: 25797861 [TBL] [Abstract][Full Text] [Related]
59. Randomized trial of risk information formats in direct-to-consumer prescription drug advertisements. Aikin KJ; O'Donoghue AC; Swasy JL; Sullivan HW Med Decis Making; 2011; 31(6):E23-33. PubMed ID: 21690303 [TBL] [Abstract][Full Text] [Related]
60. How Affiliation Disclosure and Control Over User-Generated Comments Affects Consumer Health Knowledge and Behavior: A Randomized Controlled Experiment of Pharmaceutical Direct-to-Consumer Advertising on Social Media. DeAndrea DC; Vendemia MA J Med Internet Res; 2016 Jul; 18(7):e189. PubMed ID: 27435883 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]